Human erythrocytes carry several transmembrane glycoproteins, among which the two minor species associated with the blood group Gerbich (Ge) antigens, GP C and GP D, play pivotal role since they interact with the membrane cytoskeleton and contribute to maintain the normal red cell shape. On the red cells from two categories of homozygous donors lacking the Ge determinants (Ge:‐1,‐2,‐3 and Ge:‐1,‐2,3), GP C and GP D are missing but instead there is a new glycoprotein, easily detected by SDS/polyacrylamide gel electrophoresis, which exhibits some properties shared by GP C and GP D. This was shown by immunochemical analyses with a murine monoclonal antibody, extraction of the glycoproteins by organic solvents and binding studies with the 125I‐labelled Lens culinaris lectin. The red cells from obligate heterozygotes for the Ge:‐1,‐2,‐3 condition also carry this new glycoprotein component but in a much lesser amount than expected on the basis of one gene dose response.
Using a cDNA probe containing the coding sequence of human GP C and the entire 3′ untranslated region of its mRNA, we have demonstrated by Southern analyses that the Ge:‐1,‐2,‐3 and the Ge:‐1,‐2,3 conditions are associated with a constant 3‐kbp deletion within the GP C gene. Similar studies indicated that this gene is present as a unique copy per haploid genome of Ge‐positive control donors (Ge:1,2,3).
To account for these data and for the glycoprotein profile of Ge‐negative erythrocytes, it is proposed that a unique Gerbich gene encodes for GP C and GP D, either by alternative RNA splicing or by different posttranslational events, and that, following a 3‐kbp deletion within this gene, a new glycoprotein having properties common to GP C and GP D can be produced.